Expired CME Article
Adenosquamous Carcinoma of the Pancreas: A Distinct Clinicopathologic Entity
Abstract
Among exocrine pancreatic tumors, adenosquamous carcinoma (ASC) is a rare, aggressive subtype with a worse prognosis and a higher potential for metastases compared to its more conventional glandular counterpart, adenocarcinoma. The disease distribution shows an approximately 1:1 male/female ratio and a median survival of circa five months. Although such features as central necrosis and hypervascularity are suggestive of pancreatic ASC, more research is necessary to identify other, more specific markers for this tumor subtype. Humoral hypercalcemia of malignancy has also been described with ASC of the pancreas, likely as a result of PTHrP production by the squamous component of the tumor. Similar to the therapeutics of pancreatic adenocarcinoma, adjuvant chemotherapy or chemoradiotherapy is currently indicated for resectable ASC of the pancreas, while gemcitabine or gemcitabine combinations are used for a more advanced disease. Both pathologic and molecular features of pancreatic ASC characterize it as a distinct subtype of pancreatic cancer. As a result, its molecular and genetic makeup could be exploited for both diagnostic and therapeutic quests in the future.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Ahlgren JD. Epidemiology and risk factors in pancreatic cancer. Semin Oncol 1996;23:241–250.
2. American Cancer Society. Facts and Figures, Atlanta, GA, American Cancer Society, Inc, 2006.
3. Herxheimer G. Uber heterologe cancroide. Beitr Pathol Anat 1907;41:348–412.
4. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas, in Silverberg SG, Sobin LH (eds):AFIP Atlas of Tumor Pathology, Series 4, Fascicle 6. Washington, DC, American Registry of Pathology, 2007, pp 177–181.
5. Kardon DE, Thompson LD, Przygodzki RM, et al. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Mod Pathol 2001;14:443–451.
6. Murakami Y, Yokoyama T, Yokoyama Y, et al. Adenosquamous carcinoma of the pancreas: preoperative diagnosis and molecular alterations. J Gastroenterol 2003;38:1171–1175.
7. Mori M, Fukuda T, Enjoji M. Adenosquamous carcinoma of the stomach. Histogenetic and ultrastructural studies. Gastroenterology 1987;92:1078–1082.
8. Al-Doroubi QI, Petrelli M, Reid JD. Adenoacanthoma of the sigmoid colon: report of a case. Dis Colon Rectum 1970;13:390–393.
9. Marshall D, Sedlis A, Tchertkoff V. Adenoacanthoma of the corpus uteri with distant metastases. Report of a case. Obstet Gynecol 1963;22:578–582.
10. Kay S. Mucoepidermoid carcinoma of the esophagus. Report of two cases. Cancer 1968;22:1053–1059.
11. Morson BC, Volkstädt H. Muco-epidermoid tumors of the anal canal. J Clin Pathol 1963;16:200–205.
12. Sheets JL, Dockerty MB, Decker DG, et al. Primary epithelial malignancy in the vagina. Am J Obstet Gynecol 1964;89:121–129.
13. Yamaguchi K, Enjoji M. Adenosquamous carcinoma of the pancreas: a clinicopathologic study. J Surg Oncol 1991;47:109–116.
14. Madura JA, Jarman BT, Doherty MG, et al. Adenosquamous carcinoma of the pancreas. Arch Surg 1999;134:599–603.
15. Cihak RW, Kawashima T, Steer A. Adenoacanthoma (adenosquamous carcinoma) of the pancreas. Cancer 1972;29:1133–1140.
16. Voong KR, Davison J, Pawlik TM, et al. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients .Hum Pathol 2010;41:113–122.
17. Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol 2008;3:157–188.
18. Halpert B, Makk L, Jordan GLJ. A retrospective study of 120 patients with carcinoma of the pancreas. Surg Gynecol Obstetr 1965;121:91–96.
19. Baylor SM, Berg JW. Cross-classification and survival characteristics of 5,000 cases of cancer of the pancreas. J Surg Oncol 1973;5:335–358.
20. Kissane JM. Carcinoma of the exocrine pancreas: pathologic aspects. J Surg Oncol1975;7:167–174.
21. Cubilla AL, Fitzgerald PJ. Classification of pancreatic cancer (nonendocrine). Mayo Clin Proc1979;54:449–458.
22. Ishikawa O, Matsui Y, Aoki I, et al. Adenosquamous carcinoma of the pancreas: a clinicopathologic study and report of three cases. Cancer 1980;46:1192–1196.
23. Morohoshi T, Held G, Klöppel G. Exocrine pancreatic tumors and their histological classification. A study based on 167 autopsy and 97 surgical cases. Histopathology 1983;7:645–661.
24. Chen J, Baithun SI. Morphological study of 391 cases of exocrine pancreatic tumors with special reference to the classification of exocrine pancreatic carcinoma. J Pathol 1985;146:17–29.
25. Motojima K, Tomioka T, Kohara N, et al. Immunohistochemical characteristics of adenosquamous carcinoma of the pancreas. J Surg Oncol 1992;49:58–62.
26. Hsu JT, Chen HM, Wu RC, et al. Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma. World J Surg Oncol 2008;6:95.
27. Fitzgerald TL, Hickner ZJ, Schmitz M, et al. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas 2008;37:134–138.
28. Rahemtullah A, Misdraji J, Pitman MB. Adenosquamous carcinoma of the pancreas: cytologic features in 14 cases. Cancer 2003;99:372–378.
29. Brody JR, Costantino CL, Potoczek M, et al. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma. Mod Pathol 2009;22:651–659.
30. Inoue T, Nagao S, Tajima H, et al. Adenosquamous pancreatic cancer producing parathyroid hormone-related protein. J Gastroenterol 2004;39:176–180.
31. Kobayashi N, Higurashi T, Iida H, et al. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM). J Hepatobiliary Pancreat Surg 2008;15:531–535.
32. Okabayashi T, Hanazaki K. Surgical outcome of adenosquamous carcinoma of the pancreas. World J Gastroenterol 2008;14:6765–6770.
33. Komatsuda T, Ishida H, Konno K, et al. Adenosquamous carcinoma of the pancreas: report of two cases. Abdom Imaging 2000;25:420–423.
34. Nakaizumi A, Tatsuta M, Uehara H, et al. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. The endoscopic retrograde intraductal catheter aspiration cytologic technique. Cancer 1992;70:2610–2614.
35. Lozano MD, Panizo A, Sola IJ, et al. FNAC guided by computed tomography in the diagnosis of primary pancreatic adenosquamous carcinoma. A report of three cases. Acta Cytol 1998;42:1451–1454.
36. Nabae T, Yamaguchi K, Takahata S, et al. Adenosquamous carcinoma of the pancreas: report of two cases. Am J Gastroenterol 1998;93:1167–1170.
37. Kuji I, Sumiya H, Taki J, et al. Intense Ga-67 uptake in adenosquamous carcinoma of the pancreas. Ann Nucl Med 1997;11:41–43.
38. Kennedy TD, Martin NL, Robinson RG, et al. Identification of an infected pseudocyst of the pancreas with 67Ga-citrate: case report. J Nucl Med 1975;16:1132–1134.
39. Hsu JT, Yeh CN, Chen YR, et al. Adenosquamous carcinoma of the pancreas. Digestion 2005;72:104–108.
40. Smoot RL, Zhang L, Sebo TJ, et al. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care. J Am Coll Surg 2008;207:368–370.
41. Tanaka N, Ohoida J, Matuno T, et al. Response of adenosquamous carcinoma of the pancreas to interferon-alpha, tumor necrosis factor-alpha and 5-fluorouracil combined treatment. Anticancer Res 1994;14:2739–2742.
42. Kovi J. Adenosquamous carcinoma of the pancreas: a light and electron microscopic study. Ultrastruct Pathol 1982;3:17–23.
43. Campman SC, Fajardo MA, Rippon MB, et al. Adenosquamous carcinoma arising in a mucinous cystadenoma of the pancreas. J Surg Oncol 1997;64:159–162.
